Escobar, Giulia
Barbarossa, Luigi
Barbiera, Giulia
Norelli, Margherita
Genua, Marco
Ranghetti, Anna
Plati, Tiziana
Camisa, Barbara
Brombin, Chiara
Cittaro, Davide http://orcid.org/0000-0003-0384-3700
Annoni, Andrea
Bondanza, Attilio
Ostuni, Renato
Gentner, Bernhard
Naldini, Luigi
Article History
Received: 16 March 2018
Accepted: 14 June 2018
First Online: 24 July 2018
Change Date: 30 August 2018
Change Type: Update
Change Details: This Article was originally published without the accompanying Peer Review File. This file is now available in the HTML version of the Article; the PDF was correct from the time of publication.
Competing interests
: L.N. and B.G. are inventors of patents filed by the San Raffaele Scientific Institute and Telethon Foundation related to technologies described in the present manuscript and own equity on Genenta Science, a biotechnology startup aimed at developing IFN gene therapy by tumor-infiltrating monocytes (ExternalRef removed). The remaining authors declare no competing interests.